Can psilocybin bring on a meaningful mystical experience? The 2006 Johns Hopkins study
Photo: Sebastien Gabriel on Unsplash
The question
For centuries, people have described rare moments of deep unity, peace and meaning. Researchers call these "mystical-type experiences". They are hard to study, because they usually arrive without warning.
A team at Johns Hopkins University wanted to know two things. Can psilocybin (the active compound in "magic mushrooms") bring on such experiences under careful, controlled conditions? And if it does, do people still find them meaningful weeks later?
Who took part and what happened
The study included 36 healthy adults aged 24 to 64 (average age 46; 14 men). None had ever used a hallucinogen. All took part in some kind of religious or spiritual practice. People with a personal history of serious medical or psychiatric illness, or a family history of psychosis or bipolar disorder, were not included.
The study was double-blind (neither the volunteers nor the staff in the room were told which substance was given that day). Thirty volunteers had two sessions about two months apart. In one, they took psilocybin (30 mg per 70 kg of body weight, a high dose). In the other, they took methylphenidate (a stimulant, used here as a comparison that also produces noticeable effects). The order was decided in advance and balanced across the group. Six more volunteers were added mainly to make it harder to guess the design.
Each session lasted about eight hours in a calm room set up like a living room. Volunteers lay on a couch with an eye mask and headphones playing music. Two trained monitors stayed with them the whole time. Two months later, they filled out questionnaires. The team also phoned three friends, family members or colleagues of each volunteer and asked whether they had noticed any changes.
What they found
- Mystical-type experiences were common. After psilocybin, 22 of 36 volunteers (about 6 in 10) met the study's criteria for a "complete" mystical experience. After methylphenidate, 4 of 36 did.
- The experience felt deeply meaningful. Two months later, 67% (about 2 in 3) rated the psilocybin session as the single most meaningful experience of their life or among their top five.
- Spiritual significance. 33% rated it as the single most spiritually significant experience of their life, and another 38% placed it among their top five.
- Well-being. 79% (about 4 in 5) reported that their well-being or life satisfaction had increased moderately or very much. None reported a decrease.
- Others noticed small changes too. The friends and family who were interviewed reported small but measurable positive changes in the volunteers' attitudes and behavior.
The experience was not easy for everyone. About 31% of volunteers (11 of 36) reported strong or extreme fear at some point during the psilocybin session. For about 22%, this anxiety colored much of the session. About 17% had brief moments of suspicious or paranoid thinking. These passed during the session with reassurance from the monitors. No lasting harmful effects were reported at the time the paper was written.
What this study does not tell us
- Small, specific group. Thirty-six people is a small number. They were well-educated, psychologically stable, and already interested in spirituality. That may have made them more likely to describe the experience in spiritual terms.
- Expectations. Volunteers were told what kinds of effects might happen. Their expectations could have shaped what they felt and reported.
- The blinding was not perfect. Monitors guessed the substance wrongly in 23% of sessions, but most of the time they could tell. Strong effects are hard to hide.
- Short follow-up. The main results come from two months after the sessions. A longer follow-up was still under way when this paper was published.
- Careful conditions. Volunteers were screened, prepared, and supported by trained staff in a controlled room. Results may not be the same in other settings.
Why it matters
This was one of the first modern, carefully controlled studies of psilocybin in healthy people. It showed that, under supportive conditions, a single high dose often led to experiences that people later counted among the most meaningful of their lives. It also showed, honestly, that a large share of people went through real fear along the way.
The study opened the door to later research on psilocybin and personality, well-being, and emotional distress. It also highlighted how much preparation, setting and support shape what people experience.
This is a summary of published research for general information. It is not medical advice. The study took place in a clinical research setting with medical screening and professional support.
Source: Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283. doi:10.1007/s00213-006-0457-5 · PubMed
More research
